STUDY OBJECTIVES: We sought to provide an updated systematic review and meta-analysis of studies investigating the effect of positive airway pressure (PAP) treatment for obstructive sleep apnea (OSA) on systolic and diastolic blood pressure (SBP, DBP). METHODS: Two independent investigators undertook a systematic search of the PubMed database (1980-2012) to identify randomized controlled trials comparing therapeutic PAP to sham-PAP, pill placebo, or standard care over at least one week in adult OSA patients without major comorbidities. The mean, variance, and sample size for diurnal and nocturnal SBP and DBP data were also extracted independently from each study. Random effects meta-analyses were conducted, followed by pre-specified subgroup and meta-regression analyses. RESULTS: 32 studies were identified, with data available from 28 studies representing n = 1,948 patients. The weighted mean difference in diurnal SBP (-2.58 mm Hg, 95% CI -3.57 to -1.59 mm Hg) and DBP (-2.01 mm Hg, 95% CI -2.84 to -1.18 mm Hg) both significantly favored PAP treatment over control arms, with similar results seen in nocturnal readings. Statistically significant reductions in BP were seen in studies whose patients were younger, sleepier, had more severe OSA, and exhibited greater PAP adherence. Meta-regression indicated that the reductions in DBP with PAP were predicted by mean baseline BP (β = -0.22, p = 0.02) and Epworth Sleepiness Scale scores (β = -0.27, p = 0.04). CONCLUSIONS: PAP treatment for OSA is associated with modest but significant reductions in diurnal and nocturnal SBP and DBP. Future research should be directed towards identifying subgroups likely to reap greater treatment benefits as well as other therapeutic benefits provided by PAP therapy.
STUDY OBJECTIVES: We sought to provide an updated systematic review and meta-analysis of studies investigating the effect of positive airway pressure (PAP) treatment for obstructive sleep apnea (OSA) on systolic and diastolic blood pressure (SBP, DBP). METHODS: Two independent investigators undertook a systematic search of the PubMed database (1980-2012) to identify randomized controlled trials comparing therapeutic PAP to sham-PAP, pill placebo, or standard care over at least one week in adult OSA patients without major comorbidities. The mean, variance, and sample size for diurnal and nocturnal SBP and DBP data were also extracted independently from each study. Random effects meta-analyses were conducted, followed by pre-specified subgroup and meta-regression analyses. RESULTS: 32 studies were identified, with data available from 28 studies representing n = 1,948 patients. The weighted mean difference in diurnal SBP (-2.58 mm Hg, 95% CI -3.57 to -1.59 mm Hg) and DBP (-2.01 mm Hg, 95% CI -2.84 to -1.18 mm Hg) both significantly favored PAP treatment over control arms, with similar results seen in nocturnal readings. Statistically significant reductions in BP were seen in studies whose patients were younger, sleepier, had more severe OSA, and exhibited greater PAP adherence. Meta-regression indicated that the reductions in DBP with PAP were predicted by mean baseline BP (β = -0.22, p = 0.02) and Epworth Sleepiness Scale scores (β = -0.27, p = 0.04). CONCLUSIONS: PAP treatment for OSA is associated with modest but significant reductions in diurnal and nocturnal SBP and DBP. Future research should be directed towards identifying subgroups likely to reap greater treatment benefits as well as other therapeutic benefits provided by PAP therapy.
Authors: Malcolm Kohler; Anne-Christin Stoewhas; Lisa Ayers; Oliver Senn; Konrad E Bloch; Erich W Russi; John R Stradling Journal: Am J Respir Crit Care Med Date: 2011-11-15 Impact factor: 21.405
Authors: Joaquín Durán-Cantolla; Felipe Aizpuru; Jose María Montserrat; Eugeni Ballester; Joaquín Terán-Santos; Jose Ignacio Aguirregomoscorta; Mónica Gonzalez; Patricia Lloberes; Juan Fernando Masa; Mónica De La Peña; Santiago Carrizo; Mercedes Mayos; Ferrán Barbé Journal: BMJ Date: 2010-11-24
Authors: Luciano F Drager; Rodrigo P Pedrosa; Patrícia M Diniz; Luzia Diegues-Silva; Bianca Marcondes; Roberta B Couto; Dante M A Giorgi; Eduardo M Krieger; Geraldo Lorenzi-Filho Journal: Hypertension Date: 2011-01-17 Impact factor: 10.190
Authors: Ferran Barbé; Joaquín Durán-Cantolla; Francisco Capote; Monica de la Peña; Eusebi Chiner; Juan F Masa; Mónica Gonzalez; Jose M Marín; Francisco Garcia-Rio; Josefa Diaz de Atauri; Joaquín Terán; Mercedes Mayos; Carmen Monasterio; Felix del Campo; Sivia Gomez; Manuel Sanchez de la Torre; Montse Martinez; José M Montserrat Journal: Am J Respir Crit Care Med Date: 2009-12-10 Impact factor: 21.405
Authors: Patricia K Nguyen; Chandra K Katikireddy; Michael V McConnell; Clete Kushida; Phillip C Yang Journal: J Cardiovasc Magn Reson Date: 2010-09-03 Impact factor: 5.364
Authors: Maree Barnes; R Douglas McEvoy; Siobhan Banks; Natalie Tarquinio; Christopher G Murray; Norman Vowles; Robert J Pierce Journal: Am J Respir Crit Care Med Date: 2004-06-16 Impact factor: 21.405
Authors: Nicholas J Scalzitti; Peter D O'Connor; Skyler W Nielsen; James K Aden; Matthew S Brock; David M Taylor; Vincent Mysliwiec; Gregory R Dion Journal: J Clin Sleep Med Date: 2018-05-15 Impact factor: 4.062
Authors: Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz Journal: Clin Res Cardiol Date: 2018-04-12 Impact factor: 5.460